Medicine

Senolytics target cellular senescence-- yet can they decrease aging?

.In the 1960s, US anatomist Leonard Hayflick monitored that replicative tissues possess a limited variety of branches, triggered in part through telomere shortening as well as later on termed the Hayflick limit. He saw that some tissues ceased portioning yet rejected to die, a process called senescence that has actually considering that been implicated in a lot of diseases and also is right now being targeting by biotech and also pharmaceutical companies.The Scientific Pipe is a column on translational and clinical research study, from bench to bedside.